Cholangiocarcinoma: preventing invasion as anti-cancer strategy

被引:4
|
作者
Gores, GJ [1 ]
机构
[1] Mayo Med Sch Clin & Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
D O I
10.1016/S0168-8278(03)00125-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:671 / 673
页数:3
相关论文
共 50 条
  • [1] Anti-Cancer Activity of Verteporfin in Cholangiocarcinoma
    Golino, Jihye L.
    Wang, Xin
    Bian, Jing
    Ruf, Benjamin
    Kelly, Michael
    Karim, Baktiar O.
    Cam, Maggie C.
    Xie, Changqing
    CANCERS, 2023, 15 (09)
  • [2] Anti-cancer mechanism of latrunculin B against cholangiocarcinoma
    Kwak, Tae Won
    Jeong, Young-Il
    Kang, Dae Hwan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 34 - 35
  • [3] Copper deficiency as an anti-cancer strategy
    Goodman, VL
    Brewer, GJ
    Merajver, SD
    ENDOCRINE-RELATED CANCER, 2004, 11 (02) : 255 - 263
  • [4] HEDGEHOG INHIBITION AS AN ANTI-CANCER STRATEGY
    Raju, G. Praveen
    Pham, Diane
    VITAMINS AND HORMONES: HEDGEHOG SIGNALING, 2012, 88 : 507 - 522
  • [5] Leukotriene inhibition with anti-allergic drugs is a promising anti-cancer treatment for cholangiocarcinoma
    Kito, Yusuke
    Toyohara, Tadashi
    Sahashi, Hidenori
    Kato, Akihisa
    Hori, Yasuki
    Yoshida, Michihiro
    Kataoka, Hiromi
    CANCER SCIENCE, 2025, 116 : 1329 - 1329
  • [6] PROGRAM STRATEGY FOR THE DISCOVERY OF NEW ANTI-CANCER DRUGS
    NARAYANAN, VL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1981, 181 (MAR): : 18 - MEDI
  • [7] Modulation of Proteostasis and Proteolytic Pathways as an Anti-Cancer Strategy
    Pereira, David M.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2017, 12 (01) : 2 - 3
  • [8] Targeting the Metabolic Mevalonate Pathway as an Anti-Cancer Strategy
    Penn, L. Z.
    PANCREAS, 2017, 46 (07) : 962 - 962
  • [9] Mitochondrial iron chelation as a novel anti-cancer strategy
    Sandoval-Acuna, Cristian
    Tomkova, Veronika
    Cardenas, Natalia Torrealba
    Neuzil, Jiri
    Repkova, Krystina
    Stursa, Jan
    Werner, Lukas
    Truksa, Jaroslav
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 120 : S61 - S61
  • [10] Unraveling proteomic changes related to anti-cancer mechanism of ivermectin in gemcitabineresistant cholangiocarcinoma
    Intuyod, Kitti
    Chomwong, Sasitorn
    Thongpon, Phonpilas
    Pongking, Thatsanapong
    Pinlaor, Somchai
    Pairojkul, Chawalit
    CANCER SCIENCE, 2025, 116 : 1680 - 1680